Sri Kosuri of Octant - The Future of Drugs, Synthetic Biology, and Complex Diseases

Build The Future

In this episode of Build The Future, we talk with Sri Kosuri, CEO & co-founder of Octant. At Octant they engineer biology to design multi-targeted small molecule drug leads to transform the treatment of society’s most complex diseases. We talk about their drug discovery engine, engineering biology, genetics, advances in biotech, and much more!
Links Mentioned

• Octant Launches Polypharmacology Drug Discovery Engine for Complex Diseases with $30 Million Series A Financing Led by Andreessen Horowitz article on biospace.com

To listen to more episodes and stay connected, follow along at:

• https://www.buildthefuturepodcast.com/
• https://twitter.com/camwiese

Don’t forget to leave a review and subscribe.
Have a great week and until next time, go build!

Thanks for listening to this episode of Build The Future.
Want more insights about the future?
Sign up for updates, new episodes, and essays about the future at https://camwiese.com/
Watch full episodes + video
Youtube Full Episodes: https://www.youtube.com/@CamWieseX
Get in touch, recommend guests, or say hello:
X: https://twitter.com/camwiese